Health officials call for adult vaccine campaign; Could tomatos hold Alzheimer's vaccine key?;

Vaccine Market

Public health officials in the U.S. say the country needs to develop a national program that highlights the need for adult vaccines that is as effective as the campaign for childhood vaccines. Report

India's Panacea Biotech says the WHO has pre-qualified a combination vaccine that guards against five childhood diseases. The qualification makes the vaccine eligible for purchase by UN agencies. Story

As of next fall, all 12-year-old girls in the Netherlands will be vaccinated against HPV. Report

Vaccine Research

Avir Green Hills Biotechnology is preparing a Phase I trial of its intranasal pandemic flu vaccine. Story

Researchers at Penn say they've been advancing their work on a single DNA vaccine that animal tests indicate could provide protection against multiple strains of flu, including pandemic versions. Report

Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for Cancer Research. Release

The humble tomato could be a suitable carrier for an oral vaccine against Alzheimer's disease, according to HyunSoon Kim from the Korea Research Institute of Bioscience and Biotechnology in Korea and colleagues from Digital Biotech and the Department of Biological Science at Wonkwang University. Release

Researchers at Scripps have revealed the shape of the Ebola virus spike protein, which is necessary for viral entry into human cells. Release

Suggested Articles

Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

AstraZeneca scored a $1 billion contribution from the United States for development, production and delivery of its potential COVID-19 vaccine.